Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07130539 · ClinicalTrials.gov registry record · NA
Mediterranean-DASH Intervention for Neurodegenerative Delay and High-Intensity Interval Training in Adults With Hypertension
A NA study of Obesity & Overweight and Sedentary, sponsored by Texas Woman's University.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT07130539: Active NA study of Obesity & Overweight and Sedentary, sponsored by Texas Woman's University.
NCT07130539 is a NA study of Obesity & Overweight and Sedentary that is active but no longer recruiting, run by Texas Woman's University. The registered enrollment target is 10 participants, below the 115-participant average among 28 other Obesity & Overweight trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07130539, a NA study of Obesity & Overweight and Sedentary, is active but no longer recruiting, sponsored by Texas Woman's University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot study examines whether a 4-week diet and exercise intervention can improve blood pressure, heart health, and sleep in physically inactive individuals with high blood pressure and overweight or obesity.
Primary Outcome
Adherence to the lifestyle intervention will be determined by ≥ 75% supervised exercise training visits completed and ≥ 75% dietary compliance.
Conditions Studied
Interventions
- OTHER MIND HIIT
Study Locations (1)
Texas
- Texas Woman's University Houston Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-03-11 |
| Est. Completion | 2025-12-25 |
| Phase | NA |
What the registry record for NCT07130539 still lists
NCT07130539 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 115-participant average among 28 other Obesity & Overweight trials with a reported enrollment target (91% lower).
The record links to 3 conditions, with Obesity & Overweight appearing as the primary indexed condition, and to 1 intervention - of which MIND HIIT is the first listed.
NCT07130539 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07130539 about?
NCT07130539 is a clinical study titled "Mediterranean-DASH Intervention for Neurodegenerative Delay and High-Intensity Interval Training in Adults With Hypertension". This pilot study examines whether a 4-week diet and exercise intervention can improve blood pressure, heart health, and sleep in physically inactive individuals with high blood pressure and overweight or obesity.
What is the current status of trial NCT07130539?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-03-11. Estimated completion is 2025-12-25.
What conditions does trial NCT07130539 study?
This clinical trial studies the following conditions: Obesity & Overweight, Sedentary, Hypertension (HTN).
What interventions are being tested in trial NCT07130539?
The interventions under investigation include: MIND HIIT (OTHER).
Who is sponsoring clinical trial NCT07130539?
This trial is sponsored by Texas Woman's University, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07130539 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity & Overweight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07130539's enrollment target sits among peer trials
10 29th of 28 the lowest of 28 other Obesity & Overweight trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity & Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity
RECRUITING · NA
-
Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment
RECRUITING · NA
-
Pistachio Intake and Nutrition-Related Outcomes in Individuals on GLP-1 Therapy
RECRUITING · NA
-
Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults
RECRUITING · NA
-
Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
RECRUITING · NA
-
Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI